Aldosterone-producing Adenoma
Aldosterone-producing Adenoma - Related Videos
08:31
Three-dimensional Alginate-bead Culture of Human Pituitary Adenoma Cells
0 Views •
Cited by 5 •
2016
Three-dimensional culture in alginate beads, due to its simplicity and reproducibility, was chosen to maintain the pituitary adenoma cells. The procedures included an initial enzymatic digestion and mechanical dissociation of the tumor tissue, and the subsequent cell suspension was encapsulated in alginate beads.
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
0 Views •
Cited by 18 •
2018
The aim of this paper is to describe the different steps of the endoscopic endonasal approach to the sella turcica.
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
0 Views •
Cited by 44 •
2017
'Super-selective' adrenal venous sampling (ssAVS, also called segmental adrenal venous sampling: sAVS) was performed using a micro-catheter to identify adrenal segment(s) that produce excessive amounts of hormones. The ssAVS technique was described, cases in which adrenal segmental lesion(s) were identified by ssAVS were presented, and the usefulness of ssAVS in future adrenal research was discussed.
01:29
The Producer Price Index
0 Views •
2025
Tracking producer-level price movements is a crucial element of economic analysis and business planning. The Producer Price Index (PPI) serves this purpose by capturing average changes in the prices domestic producers receive for their goods and services over time. As a forward-looking indicator, the PPI often signals inflationary pressures before they are felt by consumers.Understanding the Structure of the PPIUnlike consumer-focused indexes, the PPI is organized around the supply side of the...
01:27
Producer Surplus for a Firm
0 Views •
2025
Producer surplus is the difference between the revenue a producer earns from selling a product and the minimum amount they are willing to accept for it. In a perfectly competitive market, producers are price takers. This means that a producer does not set their own price and sell the products at the prevailing market price. Consequently, the amount actually received by a firm is influenced by the market price of the product.The firm's willingness to supply is determined by its supply curve. In...
FAQs
Excess aldosterone changes renal electrolyte handling through mineralocorticoid receptor activation. Increased sodium reabsorption expands water retention and blood volume, contributing to hypertension, while increased potassium and hydrogen ion excretion can produce hypokalemia and metabolic alkalosis. This linked pattern helps clinicians connect biochemical abnormalities with the hormonal mechanism and recognize a potentially endocrine cause of high blood pressure.
It can identify hypertension with an endocrine cause that may be specifically treated, rather than managed only as nonspecific elevated blood pressure. The finding also connects pressure elevation to autonomous aldosterone activity and its renal effects. In medicine, this distinction matters because evaluation may lead to adrenalectomy or receptor-blocking therapy, depending on the assessed source and treatment plan.
Biochemical testing is important because imaging addresses adrenal structure, whereas hormone testing addresses function. The evaluation seeks evidence that aldosterone secretion is excessive and autonomous, linking the adrenal lesion to primary aldosteronism. This distinction matters clinically because an adrenal abnormality must be interpreted alongside biochemical findings before treatment is directed at an endocrine source of hypertension.
Adrenal imaging contributes anatomical information after or alongside biochemical evaluation. It can identify an adrenal lesion compatible with the suspected source of aldosterone excess, while the clinical question remains whether that lesion explains the hormone abnormality. Combining structural information with functional assessment improves evaluation of a possible aldosterone-producing adenoma and supports subsequent diagnostic or treatment planning.
When adrenal venous sampling is needed, it provides additional information about the source of aldosterone secretion within the adrenal glands. This is useful when imaging does not by itself settle the evaluation, because treatment decisions depend on identifying an adrenal source that can be addressed appropriately. Sampling therefore complements biochemical testing and imaging rather than replacing them.
Laparoscopic adrenalectomy is a treatment option when the adenoma is considered a suitable removable source of excess aldosterone. By addressing the abnormal adrenal tissue, the procedure targets the cause rather than only controlling downstream effects. Its relevance is greatest when evaluation supports a localized adrenal source and the clinical goal is treatment of potentially curable endocrine hypertension.
Mineralocorticoid receptor antagonists provide a nonsurgical way to counter aldosterone’s effects. Instead of removing adrenal tissue, they block the receptor through which excess hormone alters sodium, potassium, and hydrogen ion handling. This option is relevant when medication is selected as the management approach, allowing clinicians to address the physiological consequences of aldosterone excess while treating associated hypertension.